Global Patient Recruitment Case Study

Description

  • A Phase II, double-blind, placebo controlled, randomized study to evaluate the clinical efficacy of an investigational medicine product with methotrexate (MTX) in adults with moderate to severe Rheumatoid Arthritis (RA) despite MTX
  • The study was performed in 11 countries spanning:
  •  

Challenge

  • Recruitment – the protocol required 140 patients to be enrolled with CRP >10mg/L
  • Predicted high screen-failure rate
  • Gaining regulatory approval across multiple geographies

Solution

Outcomes